List of Orphan Products Designated  for the Month of April 2008 
	Total Number of Active Designations  	9	Effective:	5/16/2008
	Generic Name	Approved Orphan Indication:
	Trade Name:
	Theralux photodynamic therapy 	Orphan Designation:
	Treatment of chronic graft versus host disease
	Designation 
	4/3/2008	Sponsor and Address
	Marketing Exclusivity 	Kiadis Pharma Canada, Inc.
	2525 Marie Curie
	Montreal (Quebec) H4S 2E1
	    
	CANADA
	***************************************************************************************
	Generic Name	Approved Orphan Indication:
	6 alpha-ethylchenodeoxycholic acid
	Trade Name:
	Orphan Designation:
	Treatment of primary biliary cirrhosis  
	Designation 
	4/9/2008	Sponsor and Address
	Marketing Exclusivity 	Intercept Pharmaceuticals, Inc.
	18 Desbrosses Street
	New York NY  10013 
	 
	***************************************************************************************
	Generic Name	Approved Orphan Indication:
	6-alpha-ethylchenodeoxycholic acid
	Trade Name:
	Orphan Designation:
	Treatment of primary sclerosing cholangitis
	Designation 
	4/9/2008	Sponsor and Address
	Marketing Exclusivity 	Intercept Pharmaceuticals, Inc.
	18 Desbrosses Street
	New York NY  10013 
	 
	***************************************************************************************
	Generic Name	Approved Orphan Indication:
	Alpha1-antitrypsin(human)
	Trade Name:
	Orphan Designation:
	Treatment of bronchiectasis
	Designation 
	4/3/2008	Sponsor and Address
	Marketing Exclusivity 	Kamada, Ltd.
	7 Sapir Street 
	Ness Ziona    
	 
	ISRAEL
	***************************************************************************************
	Generic Name	Approved Orphan Indication:
	Anti-von Willebrand Aptamer
	Trade Name:
	Orphan Designation:
	Treatment of thrombotic thrombocytopenic purpura
	Designation 
	4/9/2008	Sponsor and Address
	Marketing Exclusivity 	Archemix Corporation
	300 Third Street
	Cambridge MA  02142 
	 
	***************************************************************************************

	Generic Name	Approved Orphan Indication:
	cyclosporine A
	Trade Name:
	NOVA22007	Orphan Designation:
	Treatment of herpes simplex virus stromal keratitis
	Designation 
	4/9/2008	Sponsor and Address
	Marketing Exclusivity 	Novagali Pharma S.A.
	1 rue Pierre Fontaine
	91058 Evry cedex
	    
	FRANCE
	***************************************************************************************
	Generic Name	Approved Orphan Indication:
	peginterferon alfa-2b
	Trade Name:
	PegIntron	Orphan Designation:
	Treatment of malignant melanoma stages IIb through IV. 
	Designation 
	4/9/2008	Sponsor and Address
	Marketing Exclusivity 	Schering-Plough Corporation
	2000 Galloping Hill Road
	Kenilworth NJ  07933-0530
	 
	***************************************************************************************
	Generic Name	Approved Orphan Indication:
	recombinant human arylsulphatase A
	Trade Name:
	Orphan Designation:
	Treatment of metachromatic leukodystrophy (MLD).
	Designation 
	4/11/2008	Sponsor and Address
	Marketing Exclusivity 	Zymenex A/S
	Roskildevej 12C
	3400 Hillerod
	    
	DENMARK
	***************************************************************************************
	Generic Name	Approved Orphan Indication:
	Sodium nitrite and sodium thiosulfate
	Trade Name:
	Cyanide Antidote Kit	Orphan Designation:
	Treatment of known or suspected cyanide poisoning
	Designation 
	4/9/2008	Sponsor and Address
	Marketing Exclusivity 	Hope Pharmaceuticals
	8260 E. Gelding Drive 
	Scottsdale AZ  85260 
	 
	***************************************************************************************